Measurement of prostate-specific antigen in serum as a screening test for prostate cancer WJ Catalona, DS Smith, TL Ratliff, KM Dodds, DE Coplen, JJJ Yuan, ... New England journal of medicine 324 (17), 1156-1161, 1991 | 3186 | 1991 |
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men WJ Catalona, JP Richie, FR Ahmann, AH M’Liss, PT Scardino, ... The Journal of urology 151 (5), 1283-1290, 1994 | 2348 | 1994 |
REVEL: an ensemble method for predicting the pathogenicity of rare missense variants NM Ioannidis, JH Rothstein, V Pejaver, S Middha, SK McDonnell, ... The American Journal of Human Genetics 99 (4), 877-885, 2016 | 1847 | 2016 |
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ... Jama 279 (19), 1542-1547, 1998 | 1757 | 1998 |
Detection of organ-confined prostate cancer is increased through prostate-specific antigen—based screening WJ Catalona, DS Smith, TL Ratliff, JW Basler Jama 270 (8), 948-954, 1993 | 1377 | 1993 |
High-throughput oncogene mutation profiling in human cancer RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ... Nature genetics 39 (3), 347-351, 2007 | 1165 | 2007 |
Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results KA Roehl, M Han, CG Ramos, JAV Antenor, WJ Catalona The Journal of urology 172 (3), 910-914, 2004 | 1078 | 2004 |
Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination: enhancement of specificity with free PSA measurements WJ Catalona, DS Smith, DK Ornstein Jama 277 (18), 1452-1455, 1997 | 1051 | 1997 |
Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies WJ Catalona, GF Carvalhal, DE Mager, DS Smith The Journal of urology 162 (2), 433-438, 1999 | 1023 | 1999 |
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 J Gudmundsson, P Sulem, A Manolescu, LT Amundadottir, ... Nature genetics 39 (5), 631-637, 2007 | 1018 | 2007 |
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy AV D'Amico, MH Chen, KA Roehl, WJ Catalona New England Journal of Medicine 351 (2), 125-135, 2004 | 971 | 2004 |
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening WJ Catalona, DS Smith, RL Wolfert, TJ Wang, HG Rittenhouse, TL Ratliff, ... Jama 274 (15), 1214-1220, 1995 | 956 | 1995 |
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer DL Lamm, APM Van Der Meijden, A Morales, SA Brosman, WJ Catalona, ... The Journal of urology 147 (3), 596-600, 1992 | 937 | 1992 |
A common variant associated with prostate cancer in European and African populations LT Amundadottir, P Sulem, J Gudmundsson, A Helgason, A Baker, ... Nature genetics 38 (6), 652-658, 2006 | 911 | 2006 |
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes J Gudmundsson, P Sulem, V Steinthorsdottir, JT Bergthorsson, ... Nature genetics 39 (8), 977-983, 2007 | 867 | 2007 |
Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values DW Keetch, WJ Catalona, DS Smith The Journal of urology 151 (6), 1571-1574, 1994 | 738 | 1994 |
Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies SD Kundu, KA Roehl, SE Eggener, JAV Antenor, M Han, WJ Catalona The Journal of urology 172 (6 Part 1), 2227-2231, 2004 | 710 | 2004 |
Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels RB Nadler, PA Humphrey, DS Smith, WJ Catalona, TL Ratliff The Journal of urology 154 (2), 407-413, 1995 | 708 | 1995 |
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types T Rafnar, P Sulem, SN Stacey, F Geller, J Gudmundsson, A Sigurdsson, ... Nature genetics 41 (2), 221-227, 2009 | 704 | 2009 |
5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer WJ Catalona, DS Smith The Journal of urology 152 (5), 1837-1842, 1994 | 673 | 1994 |